CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today applauds Texas Governor Greg Abbott for vetoing Senate Bill 3, which would have created an effective ban on the sale of consumable hemp products across the state of Texas.
CV Sciences, Inc. Reports First Quarter 2025 Financial ResultsSAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2025.
